AMN HEALTHCARE SERVICES INC (AMN)

US0017441017 - Common Stock

57.19  +0.02 (+0.03%)

After market: 57.19 0 (0%)

Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to AMN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 76.35. This target is 33.51% above the current price.
AMN was analyzed by 13 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about AMN.
In the previous month the buy percentage consensus was at a similar level.
AMN was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 57.1964.6476.5076.3592.40 - 13.03% 33.76% 33.51% 61.57%
Up and Down Grades
Date Firm Action Rating
2024-04-22 Truist Securities Maintains Buy -> Buy
2024-02-26 JMP Securities Maintains Market Outperform -> Market Outperform
2024-02-20 BMO Capital Maintains Outperform -> Outperform
2024-02-16 JMP Securities Maintains Market Outperform -> Market Outperform
2023-12-06 JMP Securities Initiate Market Outperform
2023-12-05 Truist Securities Reiterate Buy -> Buy
2023-11-30 UBS Initiate Neutral
2023-11-06 Truist Securities Maintains Buy -> Buy
2023-11-03 Benchmark Downgrade Buy -> Hold
2023-11-03 Jefferies Downgrade Buy -> Hold
2023-08-07 BMO Capital Maintains Outperform -> Outperform
2023-08-04 Truist Securities Maintains Buy -> Buy
2023-08-04 Credit Suisse Maintains Outperform -> Outperform
2023-08-04 B of A Securities Downgrade Buy -> Neutral
2023-05-08 BMO Capital Maintains Outperform
2023-05-05 Benchmark Maintains Buy
2023-05-05 Credit Suisse Maintains Outperform
2023-05-02 Truist Securities Maintains Buy
2023-04-03 Credit Suisse Maintains Outperform
2023-02-21 BMO Capital Maintains Outperform
2023-02-17 Baird Maintains Neutral
2023-02-17 Credit Suisse Reiterate Outperform
2023-02-13 Benchmark Reiterate Buy
2022-11-07 BMO Capital Maintains Outperform
2022-06-16 Credit Suisse Maintains Outperform
2022-05-24 Jefferies Maintains Buy
2022-05-06 Credit Suisse Maintains Outperform
2022-02-18 Benchmark Maintains Buy
2022-02-18 Jefferies Maintains Buy
2021-11-17 Credit Suisse Maintains Outperform